Viewing Study NCT00417820


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-01-27 @ 4:59 AM
Study NCT ID: NCT00417820
Status: COMPLETED
Last Update Posted: 2007-11-29
First Post: 2007-01-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CBCT194A2101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators